AI summary · may contain errors
Immune checkpoint inhibitor related pituitary toxicity remains a relatively common complication, with diagnostic uncertainty due to subtle presentations and symptom overlap, and no validated biomarker.
- Open access
Moving in Neuro-Oncology, The Lancet Diabetes & Endocrinology, Endocrine Reviews, Acta Neuropathologica, bioRxiv, EMBO Molecular Medicine, European Heart Journal and JAMA Oncology.
Rebuilt
Nothing in this topic has moved yet this week.
Newest first · last 60 days
AI summary · may contain errors
Immune checkpoint inhibitor related pituitary toxicity remains a relatively common complication, with diagnostic uncertainty due to subtle presentations and symptom overlap, and no validated biomarker.
AI summary · may contain errors
Early achievement of complete biochemical remission within 6 months in ectopic Cushing syndrome is linked to lower late complications and Cushing syndrome-related mortality, with adjusted HRs 0·55 and 0·49.
AI summary · may contain errors
Disrupting adenomatous polyposis coli (Apc) in Sox2+ve pituitary stem cells drives adamantinomatous craniopharyngioma formation, producing classic molecular and histopathological hallmarks.
AI summary · may contain errors
Hypercortisolism is linked to worse cardio-kidney-metabolic outcomes, with MACS associated with a 2.5-fold higher risk of cardiovascular death and higher rates of hypertension, T2DM, and kidney impairment.
AI summary · may contain errors
Single-cell RNA-seq of 21 non-functioning gonadotroph (NFG) tumors and 8 anterior pituitary gland (APG) samples shows lineage infidelity linked to tumor growth, with CAD, BRF2, and SOX12 positively correlated.
AI summary · may contain errors
Paraneoplastic syndromes in neuroendocrine neoplasms are clinically important but their true prevalence remains uncertain and likely underestimated, despite advances in diagnosis and monitoring.
AI summary · may contain errors
A previously unrecognized pineal region tumor type with a distinct DNA methylation profile was defined in a cohort of 27 patients, with consistent neuroendocrine and epithelial marker expression.
AI summary · may contain errors
Biomarker-guided and systemic treatment strategies for meningioma are increasingly supported by improved understanding of tumor biology, with better trial endpoints and response assessment criteria.
AI summary · may contain errors
In Denmark, meningioma incidence rose from 6.4 to 12.6 per 100,000 person-years (2010–2023), while annual treatment rates stayed stable despite extensive follow-up MRI use.
AI summary · may contain errors
Depot medroxyprogesterone acetate (DMPA) exposure is linked to a 1.5- to 5.5-fold increased risk of meningioma in international epidemiological studies.
AI summary · may contain errors
GAL is markedly downregulated in silent corticotroph adenomas, and GAL loss promotes tumor cell proliferation by activating PI3K-Akt-mTOR and increasing SREBP1 lipogenesis activity.
Journals this month
Topics moving, week to 18 Nov 2026
By field